# Kangyu Capital

> Kangyu Capital is a VC fund in Beijing backing Medical, Health Care and Medical Device. See 11 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 11
- Last investment: Aug 2026
- Lead investor: 36%
- Last updated: Aug 2026

Kangyu Capital is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 4 | 36% |
| Health Care | 4 | 36% |
| Medical Device | 3 | 27% |
| Manufacturing | 2 | 18% |
| Retail | 1 | 9% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 27% |
| Series B | 2 | 18% |
| Seed | 1 | 9% |
| Angel | 1 | 9% |
| Series C | 1 | 9% |

6 stages tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Health Plus | Health Plus is the operator of a health insurance platform designed to provide insurance solutions for medical institutions & companies. |  | Series B | Aug 03, 2026 |  |
| Tonglu Technology | Tonglu Technology is a robot platform for vascular interventional surgery that offers intelligent surgical solutions. |  | Series A | Jul 26, 2026 |  |
| Singular Medical | Singular Medical is a technology company specializing in R&D and industrialization of cardiac rhythm management (CRM) products. The company builds a complete technical platform and is a supplier of full line of CRM products, which provides a complete range of solutions, from detection to follow-up for large amounts of cardiac patients. | $20.7M | Series C | Mar 12, 2025 |  |
| Jinjing Keji | Jinjing Keji manufactures cathode fluorescence system products. They are mainly in scientific research institutes, semiconductor industry, and electron microscope manufacturing. They provide testing services too in addition to selling the product. |  | Venture - Series Unknown | Feb 29, 2024 |  |
| Huayuan Regenerative Medicine | Huayuan Regenerative Medicine is a developer of implantable biological artificial organs. |  | Seed | Nov 20, 2023 |  |
| Tonglu Technology | Tonglu Technology is a robot platform for vascular interventional surgery that offers intelligent surgical solutions. |  | Series A | May 08, 2023 |  |
| Singular Medical | Singular Medical is a technology company specializing in R&D and industrialization of cardiac rhythm management (CRM) products. The company builds a complete technical platform and is a supplier of full line of CRM products, which provides a complete range of solutions, from detection to follow-up for large amounts of cardiac patients. |  | Series B | Jan 06, 2023 |  |
| Lab Direct | Lab Direct is a developer of an online supply chain and procurement service platform that helps laboratories and research institutions to directly connect with suppliers and potential partners to get access to necessary equipment and supplies. The company was founded in 2014 and is headquartered in Shanghai, China. | $10M | Series A | Aug 26, 2022 |  |
| Evolyzer | Evolyzer is a synthetic biology technology start-up that specializes in the biomanufacturing of chemicals, agriculture, and medicine. | $7.5M | Angel | Jun 06, 2022 |  |
| Health Plus | Health Plus is the operator of a health insurance platform designed to provide insurance solutions for medical institutions & companies. | $10M | Series B | Feb 09, 2022 |  |

10 of 11 investments shown.

## Co-investors
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 3 deals together
- [Bayland Capital](https://shizune.co/investors/profile/bayland-capital) — VC Fund, 1 deal together
- [Pins Medical](https://shizune.co/investors/profile/beijing-pins-medical-co) — VC Fund, 1 deal together
- [Dyee Capital](https://shizune.co/investors/profile/dyee-capital) — VC Fund, 1 deal together
- [Everest Venture Capital](https://shizune.co/investors/profile/everest-venture-capital) — VC Fund, 1 deal together
- [Frees Fund](https://shizune.co/investors/profile/freesfund) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Kangyu Capital invest in?

Kangyu Capital invests primarily in Medical, Health Care and Medical Device startups, most often at Series A and Series B stage. Most of the 11 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Kangyu Capital last invest?

The most recent investment recorded for Kangyu Capital closed in Aug 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co